Table of Contents

2019-2024 Global Anticoagulant Reversal Drugs Market Report (Status and Outlook)

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Anticoagulant Reversal Drugs Market Size 2014-2024
  • 2.1.2 Anticoagulant Reversal Drugs Market Size CAGR by Region
• 2.2 Anticoagulant Reversal Drugs Segment by Type
  • 2.2.1 Prothrombin Complex Concentrates (PCC)
  • 2.2.2 Vitamin K
  • 2.2.3 Protamine
  • 2.2.4 Tranexamic Acid
  • 2.2.5 Idarucizumab
  • 2.2.6 Others
• 2.3 Anticoagulant Reversal Drugs Market Size by Type
  • 2.3.1 Global Anticoagulant Reversal Drugs Market Size Market Share by Type (2014-2019)
  • 2.3.2 Global Anticoagulant Reversal Drugs Market Size Growth Rate by Type (2014-2019)
• 2.4 Anticoagulant Reversal Drugs Segment by Application
  • 2.4.1 Hospital Pharmacies
  • 2.4.2 Retail Pharmacies
  • 2.4.3 Online Pharmacies
• 2.5 Anticoagulant Reversal Drugs Market Size by Application
  • 2.5.1 Global Anticoagulant Reversal Drugs Market Size Market Share by Application (2014-2019)
  • 2.5.2 Global Anticoagulant Reversal Drugs Market Size Growth Rate by Application (2014-2019)

3 Global Anticoagulant Reversal Drugs by Players

• 3.1 Global Anticoagulant Reversal Drugs Market Size Market Share by Players
  • 3.1.1 Global Anticoagulant Reversal Drugs Market Size by Players (2017-2019)
  • 3.1.2 Global Anticoagulant Reversal Drugs Market Size Market Share by Players (2017-2019)
• 3.2 Global Anticoagulant Reversal Drugs Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Anticoagulant Reversal Drugs by Regions

• 4.1 Anticoagulant Reversal Drugs Market Size by Regions
• 4.2 Americas Anticoagulant Reversal Drugs Market Size Growth
• 4.3 APAC Anticoagulant Reversal Drugs Market Size Growth
• 4.4 Europe Anticoagulant Reversal Drugs Market Size Growth
• 4.5 Middle East & Africa Anticoagulant Reversal Drugs Market Size Growth

5 Americas

• 5.1 Americas Anticoagulant Reversal Drugs Market Size by Countries
• 5.2 Americas Anticoagulant Reversal Drugs Market Size by Type
• 5.3 Americas Anticoagulant Reversal Drugs Market Size by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Anticoagulant Reversal Drugs Market Size by Countries
• 6.2 APAC Anticoagulant Reversal Drugs Market Size by Type
• 6.3 APAC Anticoagulant Reversal Drugs Market Size by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Anticoagulant Reversal Drugs by Countries
• 7.2 Europe Anticoagulant Reversal Drugs Market Size by Type
• 7.3 Europe Anticoagulant Reversal Drugs Market Size by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Anticoagulant Reversal Drugs by Countries
• 8.2 Middle East & Africa Anticoagulant Reversal Drugs Market Size by Type
• 8.3 Middle East & Africa Anticoagulant Reversal Drugs Market Size by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Anticoagulant Reversal Drugs Market Forecast

• 10.1 Global Anticoagulant Reversal Drugs Market Size Forecast (2019-2024)
• 10.2 Global Anticoagulant Reversal Drugs Forecast by Regions
  • 10.2.1 Global Anticoagulant Reversal Drugs Forecast by Regions (2019-2024)
  • 10.2.2 Americas Market Forecast
  • 10.2.3 APAC Market Forecast
  • 10.2.4 Europe Market Forecast
  • 10.2.5 Middle East & Africa Market Forecast
• 10.3 Americas Forecast by Countries
  • 10.3.1 United States Market Forecast
  • 10.3.2 Canada Market Forecast
  • 10.3.3 Mexico Market Forecast
  • 10.3.4 Brazil Market Forecast
• 10.4 APAC Forecast by Countries
  • 10.4.1 China Market Forecast
  • 10.4.2 Japan Market Forecast
  • 10.4.3 Korea Market Forecast
  • 10.4.4 Southeast Asia Market Forecast
  • 10.4.5 India Market Forecast
  • 10.4.6 Australia Market Forecast
• 10.5 Europe Forecast by Countries
  • 10.5.1 Germany Market Forecast
  • 10.5.2 France Market Forecast
  • 10.5.3 UK Market Forecast
  • 10.5.4 Italy Market Forecast
  • 10.5.5 Russia Market Forecast
  • 10.5.6 Spain Market Forecast
• 10.6 Middle East & Africa Forecast by Countries
  • 10.6.1 Egypt Market Forecast
  • 10.6.2 South Africa Market Forecast
  • 10.6.3 Israel Market Forecast
  • 10.6.4 Turkey Market Forecast
  • 10.6.5 GCC Countries Market Forecast
• 10.7 Global Anticoagulant Reversal Drugs Forecast by Type
• 10.8 Global Anticoagulant Reversal Drugs Forecast by Application

11 Key Players Analysis

• 11.1 Pfizer
  • 11.1.1 Company Details
  • 11.1.2 Anticoagulant Reversal Drugs Product Offered
  • 11.1.3 Pfizer Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2019)
  • 11.1.4 Main Business Overview
  • 11.1.5 Pfizer News
• 11.2 Bausch Health Companies
  • 11.2.1 Company Details
  • 11.2.2 Anticoagulant Reversal Drugs Product Offered
  • 11.2.3 Bausch Health Companies Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2019)
  • 11.2.4 Main Business Overview
  • 11.2.5 Bausch Health Companies News
• 11.3 Fresenius
  • 11.3.1 Company Details
  • 11.3.2 Anticoagulant Reversal Drugs Product Offered
  • 11.3.3 Fresenius Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2019)
  • 11.3.4 Main Business Overview
  • 11.3.5 Fresenius News
• 11.4 Boehringer Ingelheim
  • 11.4.1 Company Details
  • 11.4.2 Anticoagulant Reversal Drugs Product Offered
  • 11.4.3 Boehringer Ingelheim Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2019)
  • 11.4.4 Main Business Overview
  • 11.4.5 Boehringer Ingelheim News
• 11.5 Amneal Pharmaceuticals
  • 11.5.1 Company Details
  • 11.5.2 Anticoagulant Reversal Drugs Product Offered
  • 11.5.3 Amneal Pharmaceuticals Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2019)
  • 11.5.4 Main Business Overview
  • 11.5.5 Amneal Pharmaceuticals News
• 11.6 CSL Limited
  • 11.6.1 Company Details
  • 11.6.2 Anticoagulant Reversal Drugs Product Offered
  • 11.6.3 CSL Limited Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2019)
  • 11.6.4 Main Business Overview
  • 11.6.5 CSL Limited News
• 11.7 Octapharma AG
  • 11.7.1 Company Details
  • 11.7.2 Anticoagulant Reversal Drugs Product Offered
  • 11.7.3 Octapharma AG Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2019)
  • 11.7.4 Main Business Overview
  • 11.7.5 Octapharma AG News
• 11.8 Portola Pharmaceuticals
  • 11.8.1 Company Details
  • 11.8.2 Anticoagulant Reversal Drugs Product Offered
  • 11.8.3 Portola Pharmaceuticals Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2019)
  • 11.8.4 Main Business Overview
  • 11.8.5 Portola Pharmaceuticals News
• 11.9 AMAG Pharmaceuticals
  • 11.9.1 Company Details
  • 11.9.2 Anticoagulant Reversal Drugs Product Offered
  • 11.9.3 AMAG Pharmaceuticals Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2019)
  • 11.9.4 Main Business Overview
  • 11.9.5 AMAG Pharmaceuticals News

12 Research Findings and Conclusion

North America and Europe, cumulatively, accounted for over 70% share of the global market in 2018.

According to this study, over the next five years the Anticoagulant Reversal Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Anticoagulant Reversal Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Anticoagulant Reversal Drugs market by product type, application, key companies and key regions.

This study considers the Anticoagulant Reversal Drugs value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Prothrombin Complex Concentrates (PCC)
Vitamin K
Tranexamic Acid
Idarucizumab
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Bausch Health Companies
Fresenius
Boehringer Ingelheim
Amneal Pharmaceuticals
CSL Limited
Octapharma AG
Portola Pharmaceuticals
AMAG Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Anticoagulant Reversal Drugs market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Anticoagulant Reversal Drugs market by identifying its various subsegments.
Focuses on the key global Anticoagulant Reversal Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anticoagulant Reversal Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Anticoagulant Reversal Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.